Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic Responses
Consistent with the biochemistry of coronaviruses as well established over decades, SARS-
CoV-2 makes its initial attachment to host cells through the binding of its spike protein (SP) …
CoV-2 makes its initial attachment to host cells through the binding of its spike protein (SP) …
Special Issue “COVID-19 Coagulopathy: Advances on Pathophysiology and Therapies”
E Russu, EM Arbănaşi, A Șchiopu - International Journal of Molecular …, 2024 - mdpi.com
The Special Issue on COVID-19 coagulopathy initiated one year ago aimed to shed light on
the mechanisms underlying the changes in the coagulation status making SARS-CoV-2 …
the mechanisms underlying the changes in the coagulation status making SARS-CoV-2 …
[HTML][HTML] Increased von Willebrand and Factor VIII plasma levels in gynecologic patients with Post-Acute-COVID-Sequela (PASC)/Long COVID
S Bellone, ER Siegel, DE Scheim, AD Santin - Gynecologic Oncology …, 2024 - Elsevier
Up to 30% of COVID-infected patients may develop post-acute sequelae of COVID-19
(PASC), also known as Long COVID (LC), a syndrome characterized by a variety of …
(PASC), also known as Long COVID (LC), a syndrome characterized by a variety of …
[PDF][PDF] Critical appraisal of multidrug therapy in the ambulatory management of patients with COVID-19 and hypoxemia
Critical appraisal of multidrug therapy in the ambulatory management of patients with COVID-19
and hypoxemia Page 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Critical appraisal of …
and hypoxemia Page 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Critical appraisal of …
[HTML][HTML] Long Covid in Aotearoa NZ: Risk assessment and preventive action urgently needed
Covid-19 can cause longer-term changes in health, collectively known as Long Covid. With
only four years of follow-up time to observe this evolving new virus we cannot yet see the full …
only four years of follow-up time to observe this evolving new virus we cannot yet see the full …
An Independent Analysis of a Retrospective Cohort of 30,423 Covid-19 Patients Treated at IHU-Mediterranean in Marseille, France: Part 2, a Real-life Assessment of …
V Lounnas, E Gkioulekas, M Rendell… - Archives of …, 2024 - scholarworks.utrgv.edu
Abstract A cohort of 30,423 Covid-19 patients treated between March 2020 and December
2021 at the IHU-Méditerranée Infection in Marseille (France) was retrospectively analyzed in …
2021 at the IHU-Méditerranée Infection in Marseille (France) was retrospectively analyzed in …
[PDF][PDF] A pandemic that won't go away–as COVID enters its 5th year, NZ needs a realistic strategy
Its offspring, JN. 1, has acquired additional changes and is causing such a wave of new
infections it could potentially be the next variant of concern, with its own Greek letter. It is …
infections it could potentially be the next variant of concern, with its own Greek letter. It is …
[PDF][PDF] Comparative Risks Cardiovascular Adverse Events of COVID-19 and other Vaccines
K Cosgrove, JA Thorp, KA Milhoan, PA McCullough⁴ - 2024 - thegms.co
Introduction: This population-based study reviewed rates of adverse events (AE's) involving
cardiac disease after COVID-19 vaccines. Methods: Data were reviewed from the US …
cardiac disease after COVID-19 vaccines. Methods: Data were reviewed from the US …